Prosecution Insights
Last updated: May 29, 2026
Application No. 18/833,169

APPARATUS FOR RADIOTHERAPY AND METHOD OF OPERATING AN APPARATUS FOR RADIOTHERAPY

Non-Final OA §102§OTHER
Filed
Jul 25, 2024
Priority
Jan 27, 2022 — EU 22153599.0 +1 more
Examiner
SONG, HOON K
Art Unit
2884
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
OA Round
1 (Non-Final)
86%
Grant Probability
Favorable
1-2
OA Rounds
6m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 86% — above average
86%
Career Allowance Rate
1302 granted / 1513 resolved
+18.1% vs TC avg
Moderate +8% lift
Without
With
+8.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 4m
Avg Prosecution
24 currently pending
Career history
1544
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
61.7%
+21.7% vs TC avg
§102
12.6%
-27.4% vs TC avg
§112
5.4%
-34.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1513 resolved cases

Office Action

§102 §OTHER
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1 and 14-15 is/are rejected under 35 U.S.C. 102a1 as being anticipated by Traneus et al. (EP 3881895). Regarding claims 1 and 14, Traneus teaches an apparatus (800) for radiotherapy or a machine-readable storage medium having computer-executable instructions stored, that, when executed, cause one or more processors to perform, comprising: at least one first radiation source (FLASH) configured to provide one or more ultra-high dose rate charged particle beams (para 8); at least one second radiation source (Non-FLASH) configured to provide one or more intensity-modulated beams (para 8); and a controller configured to: control the at least one first radiation source to generate the one or more ultra-high dose rate charged particle beams and control the at least one second radiation source to generate the one or more intensity-modulated beams such that the one or more ultra-high dose rate charged particle beams and the one or more intensity-modulated beams provide a substantially uniform total dose distribution across the target region (para 21-23). Regarding claim 15, Traneus teaches the machine-readable storage medium of claim 14 and having computer-executable instructions stored, that, when executed, cause the one or more processors to perform the functionalities of the apparatus according to claim 1 (para 21-23). Claim(s) 1 and 14-15 is/are rejected under 35 U.S.C. 102a1 as being anticipated by Bourhis et al. (EP 3928833). Regarding claims 1 and 14, Bourhis teaches an apparatus (800) for radiotherapy or a machine-readable storage medium having computer-executable instructions stored, that, when executed, cause one or more processors to perform, comprising: at least one first radiation source configured to provide one or more ultra-high dose rate charged particle beams; at least one second radiation source configured to provide one or more intensity-modulated beams (beam lines 8 and 9, para 12, 20 and 94); and a controller configured to: control the at least one first radiation source to generate the one or more ultra-high dose rate charged particle beams and control the at least one second radiation source to generate the one or more intensity-modulated beams such that the one or more ultra-high dose rate charged particle beams and the one or more intensity-modulated beams provide a substantially uniform total dose distribution across the target region (figure 3, para 27 and 96). Regarding claim 15, Bourhis teaches the machine-readable storage medium of claim 14 and having computer-executable instructions stored, that, when executed, cause the one or more processors to perform the functionalities of the apparatus according to claim 1 (para 12, 20 and 94). Allowable Subject Matter Claims 2-13 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: Regarding claims 2-13, the prior art fails to teach the controller (830) is further configured to control the at least one first radiation source (810) to generate the one or more ultra-high dose rate charged particle beams (812) and control the at least one second radiation source (820) to generate the one or more intensity-modulated beams (820) such that a first dose distribution of the one or more ultra-high dose rate charged particle beams (812) and a second dose distribution of the one or more intensity-modulated beams (820) combine in the target region (TV) to provide the substantially uniform total dose distribution across the target region (TV), in particular across substantially the entire target region (TV) as claimed in claim 2. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to HOON K SONG whose telephone number is (571)272-2494. The examiner can normally be reached M to Th 10am to 7pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Makiya can be reached at 571-272-2273. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /HOON K SONG/Primary Examiner, Art Unit 2884
Read full office action

Prosecution Timeline

Jul 25, 2024
Application Filed
Feb 27, 2026
Non-Final Rejection mailed — §102, §OTHER (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12636520
COLLIMATOR APPARATUS AND MOTION CONTROL METHOD
2y 5m to grant Granted May 26, 2026
Patent 12629542
TREATMENT PLANNING METHODS AND SYSTEMS THAT CONTROL THE UNIFORMITY OF DOSE DISTRIBUTIONS OF RADIATION TREATMENT FIELDS
3y 2m to grant Granted May 19, 2026
Patent 12629119
Cantilevered X-Ray CT System For Multi-Axis Imaging
2y 7m to grant Granted May 19, 2026
Patent 12629127
CALIBRATION PHANTOM, METHOD, AND SYSTEM
2y 5m to grant Granted May 19, 2026
Patent 12623092
DYNAMIC ADAPTATION OF RADIOTHERAPY TREATMENT PLANS
3y 2m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
86%
Grant Probability
94%
With Interview (+8.4%)
2y 4m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1513 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month